Original language | English (US) |
---|---|
Pages (from-to) | 1270-1303 |
Number of pages | 34 |
Journal | Heart Rhythm |
Volume | 11 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2014 |
Externally published | Yes |
Keywords
- Defibrillator
- Dual chamber
- ICD
- Myocardial infarction
- Nonischemic cardiomyopathy
- Revascularization
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)
Access to Document
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. / Kusumoto, Fred M.; Calkins, Hugh; Boehmer, John; Buxton, Alfred E.; Chung, Mina K.; Gold, Michael R.; Hohnloser, Stefan H.; Indik, Julia; Lee, Richard; Mehra, Mandeep R.; Menon, Venu; Page, Richard L.; Shen, Win Kuang; Slotwiner, David J.; Warner Stevenson, Lynne; Varosy, Paul D.; Welikovitch, Lisa.
In: Heart Rhythm, Vol. 11, No. 7, 07.2014, p. 1270-1303.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials
AU - Kusumoto, Fred M.
AU - Calkins, Hugh
AU - Boehmer, John
AU - Buxton, Alfred E.
AU - Chung, Mina K.
AU - Gold, Michael R.
AU - Hohnloser, Stefan H.
AU - Indik, Julia
AU - Lee, Richard
AU - Mehra, Mandeep R.
AU - Menon, Venu
AU - Page, Richard L.
AU - Shen, Win Kuang
AU - Slotwiner, David J.
AU - Warner Stevenson, Lynne
AU - Varosy, Paul D.
AU - Welikovitch, Lisa
N1 - Funding Information: Peer Reviewer Disclosure Table Peer Reviewer Consultant/Advisory Board Speakers׳ Bureau/Honoraria Research Grant Fellowship Support Board Mbs/Stock Options/Partner Others Sharon Hunt, MD None None None None None None John Burnett, MD 2: Chaire, Nile Therapeutics, Trevena, Bayer, Novartis, Merck, Anexon None None None 1: Zumbro Discovery 1: Intellectual property rights, Nile Therapeutics James R. Edgerton, MD 3: AtriCure 3: AtriCure None None None None Sana Al-Khatib, MD None None None None None None Anne Curtis, MD 1: Bristol-Myers Squibb, Janssen Pharmaceuticals, Biosense Webster, Inc., Sanofi Aventis, St. Jude Medical, Daiichi Sankyo, Pfizer, Jones & Bartlett None 2: Medtronic, Inc. None None None Valentin Fuster, MD, PhD None None None None None None David R. Holmes, Jr., MD None None None None None None Jodie L. Hurwitz, MD 1: Biosense Webster, Inc. 1: St. Jude Medical, Medtronic Inc., Boehringer Ingelheim None None None 0: Heart Rhythm Society 1: The Heart Hospital Baylor Plan, Medical City Hospital Gregory M. Marcus, MD None None 3: Medtronic, Inc., Gilead None None None 5: SentreHeart Simone Musco, MD None 1: Bristol-Myers Squibb, Pfizer None None None None Patrick T. O’Gara, MD None None None None None 1: Lantheus Medical Imaging 2: National Institutes of Health Brian Olshansky, MD 1: Boston Scientific Corp., Boehringer Ingelheim, Medtronic, Inc., BioControl Medical, Ltd., Sanofi Aventis, Amarin None None None None 1: Sanofi Aventis, Boston Scientific, Amarin Marwan Refaat, MD None None None None None None Frederico Gentile, MD None None None None None None L. Samuel Wann, MD 1: United Healthcare None None None None None
PY - 2014/7
Y1 - 2014/7
KW - Defibrillator
KW - Dual chamber
KW - ICD
KW - Myocardial infarction
KW - Nonischemic cardiomyopathy
KW - Revascularization
UR - http://www.scopus.com/inward/record.url?scp=84903155075&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903155075&partnerID=8YFLogxK
U2 - 10.1016/j.hrthm.2014.03.041
DO - 10.1016/j.hrthm.2014.03.041
M3 - Article
C2 - 24819194
AN - SCOPUS:84903155075
VL - 11
SP - 1270
EP - 1303
JO - Heart Rhythm
JF - Heart Rhythm
SN - 1547-5271
IS - 7
ER -